Plunkett Research Online: Acura Pharmaceuticals Inc

ACURA PHARMACEUTICALS INC (ACUR:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Acura Pharmaceuticals, Inc. develops product candidates providing abuse deterrent features and benefits utilizing its proprietary Aversion Technology. Its innovative Aversion Technology platform has been successfully utilized in developing multiple opioid analgesic products candidates. Development.....



Acura Pharmaceuticals Inc
Ticker: ACUR
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 847 705-7709
Fax:
Address: 616 N. North Court
Suite 120
Palatine, IL 60067 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
Robert JonesCEO/Director/President
Peter ClemensCFO/Chief Accounting Officer/Secretary/Senior VP
See More
Acura Pharmaceuticals, Inc. develops product candidates providing abuse deterrent features and benefits utilizing its proprietary Aversion Technology. Its innovative Aversion Technology platform has been successfully utilized in developing multiple opioid analgesic products candidates. Development.....See More See More

Auditor: BDO USA, LLP
Legal Advisor: LeClairRyan
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: